PRAXIS PRECISION MEDICINES, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.82 USD | +3.69% |
|
+17.76% | +152.54% |
Chart calendar Praxis Precision Medicines, Inc.
5e1c9ac6205908cc292111c119c.mixvtvfkE4NudcyDCiVLWuvmwPOqqwPPUs9LgnXj1cI.9GEW8biXZa4eD4jGYhJzbKOglafk7jS9GeI81wzOjJLNYyf02pFf0is0lQ~1483edd54f7c07fce6e69f6fe0fc4f33
Upcoming events on Praxis Precision Medicines, Inc.
Past events on Praxis Precision Medicines, Inc.
| 2024-04-17 16:48 | American Academy of Neurology Meeting |
| 2024-04-16 15:00 | American Academy of Neurology Meeting |
| 2024-04-15 | Piper Sandler Spring Biopharma Symposium |
| 2024-04-14 19:30 | American Academy of Neurology Meeting |
| 2024-04-08 08:00 | Needham Healthcare Conference |
| 2024-03-26 08:00 | Investor Meeting - Key Opinion Leader |
| 2024-03-06 10:30 | TD Cowen Health Care Conference |
| 2024-03-05 07:00 | Q4 2023 Earnings Release |
| 2023-12-04 12:00 | American Epilepsy Society Meeting - Abstract No: 3.198 |
| 2023-12-04 12:00 | American Epilepsy Society Meeting - Abstract No: 3.258 |
| 2023-12-04 12:00 | American Epilepsy Society Meeting - Abstract No: 3.455 |
| 2023-12-04 12:00 | American Epilepsy Society Meeting - Abstract No: 3.458 |
| 2023-12-03 07:00 | Behind the Seizure Scientific Meeting |
| 2023-12-01 18:15 | The Cute Syndrome Foundation Meeting |
| 2023-11-30 17:00 | Partners Against Mortality in Epilepsy Conference - Poster No: 32 |
| 2023-11-30 17:00 | Partners Against Mortality in Epilepsy Conference - Poster No: 38 |
| 2023-11-30 13:30 | SYNGAP1 Conference |
| 2023-11-28 10:00 | Piper Sandler Healthcare Conference |
| 2023-11-07 | Truist Securities Healthcare Conference |
| 2023-11-07 07:00 | Q3 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 2,45 1,97 24.13% | 2,30 |
|
EBITDA Million USD | Released Forecast Spread | -61,9 -41,8 -48.2% | -167 -157 -6.74% | -215 -214 -0.15% | -126 -124 -1.29% | -112 |
|
EBIT Million USD | Released Forecast Spread | -62,0 -49,6 -24.99% | -167 -158 -5.79% | -215 -213 -0.91% | -126 -127 0.79% | -125 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -61,8 -48,8 -26.73% | -167 -158 -5.79% | -214 -210 -1.7% | -123 -126 1.82% | -123 |
|
Net income Million USD | Released Forecast Spread | -70,3 -52,4 -34.3% | -167 -158 -5.45% | -214 -212 -0.84% | -123 -126 1.82% | -123 |
|
EPS USD | Released Forecast Spread | -27,6 -26,5 -4.25% | -59,1 -55,6 -6.26% | -69,6 -67,9 -2.5% | -18,7 -21,5 13.2% | -8,78 |
| Announcement Date | 17/03/21 | 28/02/22 | 07/02/23 | 05/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,68 0,00 - | 0,78 0,00 - | 0,47 0,00 - | 0,52 0,05 930% | 2,04 | 0,04 | 0,04 | 0,04 | 0,10 |
|
EBITDA Million USD | Released Forecast Spread | -58,6 -46,4 -26.22% | -68,8 -55,0 -24.91% | -60,3 -59,4 -1.47% | -44,2 -35,4 -24.96% | -41,3 -33,7 -22.69% | -38,0 -34,9 -8.96% | -34,9 -34,6 -0.6% | -25,4 -32,8 22.44% | -27,7 -26,1 -6.14% | -23,1 | -29,0 | -29,7 | -30,3 | |
|
EBIT Million USD | Released Forecast Spread | -58,7 -49,5 -18.52% | -68,8 -59,2 -16.22% | -60,4 -60,2 -0.4% | -44,3 -42,3 -4.77% | -41,5 -39,5 -4.94% | -38,1 -40,1 5.02% | -35,0 -36,7 4.68% | -25,5 -35,7 28.49% | -27,8 -28,8 3.44% | -27,5 | -30,8 | -32,2 | -32,6 | -36,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -58,6 -49,4 -18.57% | -68,7 -59,1 -16.17% | -60,2 -60,9 1.11% | -43,9 -44,3 0.74% | -41,2 -37,6 -9.52% | -37,5 -40,0 6.34% | -34,3 -37,7 9.01% | -24,6 -35,3 30.23% | -26,9 -28,4 5.45% | -27,3 | -30,6 | -32,0 | -32,4 | -36,2 |
|
Net income Million USD | Released Forecast Spread | -58,6 -49,9 -17.37% | -68,7 -59,2 -16.12% | -60,2 -60,1 -0.24% | -43,9 -42,2 -4.21% | -41,2 -39,4 -4.52% | -37,5 -40,0 6.34% | -34,3 -36,5 6.06% | -24,6 -35,3 30.23% | -26,9 -28,4 5.45% | -27,3 | -30,6 | -32,0 | -32,4 | -36,2 |
|
EPS USD | Released Forecast Spread | -19,5 -16,3 -19.49% | -22,6 -19,6 -15.71% | -19,8 -19,5 -1.67% | -14,4 -13,8 -4.35% | -13,0 -11,8 -10.83% | -10,6 -11,8 9.55% | -7,35 -9,84 25.3% | -2,70 -5,25 48.57% | -2,97 -3,19 6.75% | -2,08 | -2,19 | -2,27 | -2,28 | -2,65 |
| Announcement Date | 28/02/22 | 09/05/22 | 08/08/22 | 09/11/22 | 07/02/23 | 11/05/23 | 09/08/23 | 07/11/23 | 05/03/24 | - | - | - | - | - |
| Today 16:05 | QIAGEN N.V.: Q1 2024 Earnings Release |
| 2024-04-29 | CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected) |
| 2024-04-30 | AZENTA, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-05-01 06:30 | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| 2024-05-01 06:30 | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| 2024-05-01 07:00 | ALKERMES PLC: Q1 2024 Earnings Release |
| 2024-05-01 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
Past sector events for Praxis Precision Medicines, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- PRAX Stock
- Calendar Praxis Precision Medicines, Inc.
